bromocriptine has been researched along with Cardiomegaly in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Aguayo-Cerón, KA; Calzada-Mendoza, CC; Méndez-Bolaina, E; Ocharan-Hernández, ME; Romero-Nava, R | 1 |
Goto, K; Kaneko, Y; Narita, I; Otsuka, T; Saito, A; Tsuchida, Y; Yamamoto, K; Yamamoto, T | 1 |
Li, H; Li, HZ; Li, QF; Shi, S; Sun, YH; Wang, R; Xu, CQ; Zhao, YJ | 1 |
3 other study(ies) available for bromocriptine and Cardiomegaly
Article | Year |
---|---|
The regulatory effect of bromocriptine on cardiac hypertrophy by prolactin and D2 receptor modulation.
Topics: Animals; Bromocriptine; Cardiomegaly; Dopamine Agonists; Male; Myocardium; Rats; Receptors, Dopamine D2; Receptors, Prolactin | 2020 |
Upregulation of prolactin receptor in proximal tubular cells was induced in cardiac dysfunction model mice.
Topics: Acute Kidney Injury; Animals; Bromocriptine; Cardiomegaly; Disease Models, Animal; Homeostasis; Hormone Antagonists; Kidney Tubules, Proximal; Male; Mice, Inbred C57BL; Natriuresis; Potassium; Prolactin; Receptors, Prolactin; Reperfusion Injury; Sodium; Sodium Chloride, Dietary; Up-Regulation | 2014 |
Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes.
Topics: Angiotensin II; Animals; Animals, Newborn; Bromocriptine; Calcium Signaling; Cardiomegaly; Cells, Cultured; Dopamine Agonists; Dopamine Antagonists; Endothelin-1; Haloperidol; Heart Ventricles; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Phosphorylation; Protein Kinase C; Rats; Rats, Wistar; Receptors, Dopamine D2 | 2009 |